Entrada Therapeutics Inc

NASDAQ:TRDA 4:00:00 PM EDT

14.77

-0.13 (-0.87%)

4:20:41 PM EDT: $14.47 -0.30 (-2.03%)

Market Cap (Intraday)	463.71M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$14 Million
Adjusted EPS	-$0.42

See more estimates

10-Day MA	$14.82
50-Day MA	$13.19
200-Day MA	$14.24

See more pivots

Entrada Therapeutics Inc Stock, NASDAQ:TRDA

6 Tide Street, Boston, Massachusetts 02210

United States of America

Phone: +1.857.520.9158

Number of Employees: 130

http://www.entradatx.com

Description

Entrada Therapeutics, Inc. operates as a biotechnology company. It focuses on delivery of biomolecules into the cell to treat devastating diseases. The firm offers intracellular enzyme replacement therapy and protein-protein interaction inhibitors programs. The company focuses on creating and expanding pipeline of oligonucleotide, antibody, enzyme, protein and peptide programs to target and engage underlying drivers of diseases. Entrada Therapeutics was founded by Dehua Pei in September 22, 2016 and is headquartered in Boston, MA.